Weizhou Zhang, who is leading research on cancer immunotherapeutics and basic mechanisms of cancer immunology, was named co-leader of the UF Health Cancer Institute’s Immuno-Oncology and Microenvironment research program.
Change swept through executive offices at cancer centers in recent weeks, shifting top leadership at the University of Texas MD Anderson Cancer Center, Duke Cancer Institute, and the University of Florida.
